These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 15379663)

  • 1. Targeted liposomal drug delivery in cancer.
    Medina OP; Zhu Y; Kairemo K
    Curr Pharm Des; 2004; 10(24):2981-9. PubMed ID: 15379663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Albumin-Encapsulated Liposomes: A Novel Drug Delivery Carrier With Hydrophobic Drugs Encapsulated in the Inner Aqueous Core.
    Okamoto Y; Taguchi K; Yamasaki K; Sakuragi M; Kuroda S; Otagiri M
    J Pharm Sci; 2018 Jan; 107(1):436-445. PubMed ID: 28826882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposomal Nanotechnology for Cancer Theranostics.
    Yue X; Dai Z
    Curr Med Chem; 2018; 25(12):1397-1408. PubMed ID: 28266269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-circulating liposomes.
    Oku N; Namba Y
    Crit Rev Ther Drug Carrier Syst; 1994; 11(4):231-70. PubMed ID: 7664348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposomal Delivery Systems: Design Optimization and Current Applications.
    Abu Lila AS; Ishida T
    Biol Pharm Bull; 2017; 40(1):1-10. PubMed ID: 28049940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucuronate-modified, long-circulating liposomes for the delivery of anticancer agents.
    Oku N; Namba Y
    Methods Enzymol; 2005; 391():145-62. PubMed ID: 15721379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Basic study and application of functional liposomes].
    Oku N
    Yakugaku Zasshi; 1995 Jul; 115(7):483-98. PubMed ID: 7562396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [PEG-liposome in DDS and clinical studies].
    Maruyama K
    Nihon Rinsho; 1998 Mar; 56(3):632-7. PubMed ID: 9549348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomal Drug Delivery and Its Potential Impact on Cancer Research.
    Bhattacharya S; Saindane D; Prajapati BG
    Anticancer Agents Med Chem; 2022 Aug; 22(15):2671-2683. PubMed ID: 35440318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyethylene glycol-coated (pegylated) liposomal doxorubicin. Rationale for use in solid tumours.
    Gabizon A; Martin F
    Drugs; 1997; 54 Suppl 4():15-21. PubMed ID: 9361957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Approaches to Address PK-PD Challenges of Conventional Liposome Formulation with Special Reference to Cancer, Alzheimer's, Diabetes, and Glaucoma: An Update on Modified Liposomal Drug Delivery System.
    Kesharwani P; Kumari K; Gururani R; Jain S; Sharma S
    Curr Drug Metab; 2022; 23(9):678-692. PubMed ID: 35692131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use and importance of liposomes in positron emission tomography.
    Silindir M; Özer AY; Erdoğan S
    Drug Deliv; 2012 Jan; 19(1):68-80. PubMed ID: 22211758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release.
    Andresen TL; Jensen SS; Jørgensen K
    Prog Lipid Res; 2005 Jan; 44(1):68-97. PubMed ID: 15748655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transferrin-targeted, resveratrol-loaded liposomes for the treatment of glioblastoma.
    Jhaveri A; Deshpande P; Pattni B; Torchilin V
    J Control Release; 2018 May; 277():89-101. PubMed ID: 29522834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposomal Drug Delivery System for Cancer Therapy: Advancement and Patents.
    Jha S; Sharma PK; Malviya R
    Recent Pat Drug Deliv Formul; 2016; 10(3):177-183. PubMed ID: 27712569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A review on the influences of size and surface charge of liposome on its targeted drug delivery in vivo].
    Yang YF; Xie XY; Yang Y; Zhang H; Mei XG
    Yao Xue Xue Bao; 2013 Nov; 48(11):1644-50. PubMed ID: 24475700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug delivery systems. 1. site-specific drug delivery using liposomes as carriers.
    Ranade VV
    J Clin Pharmacol; 1989 Aug; 29(8):685-94. PubMed ID: 2674208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Designing of 'intelligent' liposomes for efficient delivery of drugs.
    Voinea M; Simionescu M
    J Cell Mol Med; 2002; 6(4):465-74. PubMed ID: 12611636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Companion Diagnostic
    Lee H; Gaddy D; Ventura M; Bernards N; de Souza R; Kirpotin D; Wickham T; Fitzgerald J; Zheng J; Hendriks BS
    Theranostics; 2018; 8(9):2300-2312. PubMed ID: 29721081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends and developments in liposome drug delivery systems.
    Lian T; Ho RJ
    J Pharm Sci; 2001 Jun; 90(6):667-80. PubMed ID: 11357170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.